ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MOL Moleculin Biotech Inc

0.00
0.00 (0.00%)
- - Realtime Data
Share Name Share Symbol Market Type
Moleculin Biotech Inc TG:MOL Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Shah Deniz Gas Project Investors Would Get 50% of Nabucco if Pipeline Chosen

10/01/2013 10:45am

Dow Jones News


Moleculin Biotech (TG:MOL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Moleculin Biotech Charts.

By Alessandro Torello

BRUSSELS--The companies leading the development of a giant natural gas field in Azerbaijan have agreed to fund the development of Nabucco West, one of two pipeline projects competing to carry that gas to Europe, the pipeline consortium said Thursday.

Nabucco reached an agreement about the Shah Deniz field with SOCAR--Azerbaijan's state-owned energy company--BP PLC (BP), Statoil ASA (STL.OS) and Total SA (TOT) on "joint funding of the development costs of the Nabucco West up to the pipeline selection decision for Shah Deniz' European export route," it said in a statement. The parties also agreed that the Shah Deniz companies would get a 50% stake in Nabucco, if the project will be selected to carry the gas to Europe.

The deal will be executed "shortly," Nabucco said in the statement.

Write to Alessandro Torello at alessandro.torello@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Moleculin Biotech Chart

1 Year Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

Your Recent History

Delayed Upgrade Clock